Bangor Savings Bank’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-700
Closed -$54.7K – 550
2025
Q2
$54.7K Hold
700
– – ﹤0.01% 298
2025
Q1
$50.7K Hold
700
– – ﹤0.01% 302
2024
Q4
$51.8K Hold
700
– – ﹤0.01% 297
2024
Q3
$46.2K Sell
700
-64
-8% -$4.65K ﹤0.01% 303
2024
Q2
$70.6K Buy
764
+64
+9% +$5.67K 0.01% 268
2024
Q1
$66.9K Sell
700
-9
-1% -$756 0.01% 268
2023
Q4
$54.1K Sell
709
-130
-15% -$9.05K 0.01% 291
2023
Q3
$58.1K Hold
839
– – 0.01% 279
2023
Q2
$79.1K Buy
839
+130
+18% +$11.3K 0.01% 262
2023
Q1
$58.7K Hold
709
– – 0.01% 284
2022
Q4
$53K Hold
709
– – 0.01% 297
2022
Q3
$59K Buy
709
+700
+7,778% +$67.4K 0.01% 278
2022
Q2
$1K Buy
+9
New +$932 ﹤0.01% 501

Other funds holding EW

Bangor Savings Bank's EW Position: Q3 2025 in Review

Bangor Savings Bank sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 700 shares — an estimated $54.7K sold.

Bangor Savings Bank first reported a position in EW in Q2 2022 and held it in 13 quarters. The position peaked at $79.1K in Q2 2023. 1,255 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Bangor Savings Bank reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • Bangor Savings Bank sold 700 Edwards Lifesciences shares in Q3 2025, an estimated $54.7K.
  • Bangor Savings Bank first reported a position in Edwards Lifesciences in Q2 2022 and held it in 13 quarters.
  • Bangor Savings Bank's Edwards Lifesciences position peaked at $79.1K in Q2 2023.
  • 1,255 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Bangor Savings Bank's 13F filing for Q3 2025, filed 27 Oct 2025.